Endocrine & Reproductive System Module — 4th Year MBBS

📚 Study Tip

This chapter follows the KMU learning outcomes and connects pathology, prevention and clinical gynecology in a logical sequence. First understand how each malignancy develops and presents; then use the final AIM High-Yield Review for rapid revision.

4th Year MBBS KMU Curriculum AIM Learning Cycle

📖 AIM Learning Material

Topic 16 — Gynecologic Malignancies: Cervical, Endometrial and Ovarian Cancer

Module/Theme: Endocrine + Reproduction

Understand the pathology, clinical presentation, diagnosis, staging, prevention and management principles of the three major gynecologic malignancies emphasized in this topic.

Topic Introduction

Gynecologic malignancies are cancers arising from the female reproductive tract. This chapter focuses on carcinoma of the cervix, endometrial carcinoma and ovarian carcinoma because each has a different pattern of causation, presentation and spread. Cervical cancer is strongly linked to persistent high-risk human papillomavirus infection and is particularly important because much of its burden is preventable. Endometrial carcinoma commonly produces abnormal uterine bleeding and is closely related to hormonal and precursor endometrial changes. Ovarian malignancy often remains clinically silent until disease has spread within the peritoneal cavity. By linking risk factors, pathogenesis, morphology, clinical features, investigations, staging and treatment principles, these diseases become much easier to distinguish and understand.

A. Major Types of Gynecologic Malignancy

Gynecologic cancers are classified mainly according to the organ or tissue from which they arise. For this topic, the key cancers are cervical, endometrial and ovarian malignancies. Recognizing their site of origin provides the first framework for understanding their different risk factors, clinical presentations and patterns of spread.

Major groups

Cervical carcinoma — most commonly squamous cell carcinoma; adenocarcinoma is another important type.
Endometrial carcinoma — arises from the endometrial lining of the uterine body; endometrioid carcinoma is the common major pattern.
Ovarian malignancies — include epithelial, germ-cell and sex-cord stromal tumors; epithelial carcinomas account for most malignant ovarian tumors in adults.
Vulvar carcinoma and vaginal carcinoma are additional gynecologic malignancies.
Gestational trophoblastic neoplasia represents malignant proliferation of trophoblastic tissue related to pregnancy.

The three major cancers emphasized here should not be viewed as one disease group with identical behavior. Cervical carcinoma is strongly infection-related, endometrial carcinoma is frequently linked to abnormal estrogenic stimulation or specific molecular pathways, while ovarian carcinoma commonly spreads across peritoneal surfaces before producing obvious symptoms.

AIM VISUAL 01

B. Cervical Carcinoma — Risk Factors, Pathogenesis and Prevention

Cervical carcinoma usually develops through a long sequence beginning with infection of cervical squamous epithelium by a high-risk human papillomavirus (HPV). Most HPV infections resolve, but persistent high-risk infection can produce precancerous epithelial abnormalities and eventually invasive carcinoma. This long precursor phase explains why vaccination and screening can prevent many cases.

Important risk factors

Persistent infection with an oncogenic HPV type is the central causal factor. Other factors increase the probability of acquiring HPV, failing to clear the infection or progressing from precancer to invasive malignancy.

Persistent infection with high-risk HPV, particularly oncogenic types such as HPV 16 and 18.
Early onset of sexual activity and greater lifetime exposure to sexual partners, because these increase opportunity for HPV transmission.
Smoking, which promotes local carcinogenic effects and reduces effective immune clearance.
Immunosuppression, which reduces the ability to control persistent HPV infection.
High parity and prolonged exposure to other cofactors may contribute to progression in an HPV-infected cervix.
Failure to participate in appropriate cervical screening increases the chance that a precursor lesion will remain undetected.

Pathogenesis

The most important changes occur near the transformation zone, where endocervical columnar epithelium meets squamous epithelium. This actively changing epithelial region is particularly susceptible to oncogenic HPV infection.

Persistent high-risk HPV infection → viral oncogene expression → interference with cell-cycle control → epithelial dysplasia/high-grade squamous intraepithelial lesion → stromal invasion → cervical carcinoma.

Two viral proteins are particularly important. E6 promotes loss of normal p53 tumor-suppressor activity, while E7 interferes with the retinoblastoma (RB) pathway. Loss of these cell-cycle checkpoints allows damaged epithelial cells to proliferate rather than undergo normal growth arrest or apoptosis.

Low-grade squamous intraepithelial lesions may regress, especially when HPV infection is cleared. Persistent high-grade lesions have a much greater risk of progressing to invasive carcinoma because abnormal cells occupy a greater thickness of the epithelium and accumulate further genetic damage.

Prevention

Cervical carcinoma is particularly suitable for prevention because its major causal infection can be reduced and because a recognizable precancerous phase usually precedes invasive disease.

HPV vaccination reduces infection with important oncogenic HPV types and therefore represents primary prevention.
Cervical screening using accepted cytology- and/or HPV-based methods detects women at risk before invasive cancer develops.
Evaluation and treatment of precancerous lesions interrupts progression to invasive carcinoma.
Smoking cessation removes an important modifiable cofactor.
Education regarding HPV transmission and safer sexual practices can reduce exposure.

Diagnostic distinction: Screening is intended to detect disease or precancer before symptoms appear. A woman with a visibly abnormal cervix or suspicious bleeding requires diagnostic assessment and biopsy rather than relying on a screening test alone.

AIM VISUAL 02

C. Cervical Carcinoma — Morphology, Clinical Features and Staging

Once neoplastic cervical epithelial cells cross the basement membrane and invade the underlying stroma, the lesion becomes invasive cervical carcinoma. Its gross appearance, microscopic pattern and direction of spread explain many of the symptoms and staging findings seen clinically.

Gross morphology

Most tumors arise near the transformation zone. As the carcinoma enlarges it may project outward, ulcerate the cervical surface or infiltrate deeply into the cervix and adjacent tissues.

Exophytic or fungating mass: projects from the cervical surface and may bleed easily because malignant tissue is friable.
Ulcerative lesion: produces irregular tissue destruction and necrosis.
Infiltrative lesion: spreads into the cervical stroma and may eventually extend into the parametrium.

Microscopic morphology

Squamous cell carcinoma is the classic major histological type. Malignant squamous cells invade the cervical stroma in nests, cords or irregular sheets. Well-differentiated tumors may form keratin pearls and show intercellular bridges. Poorly differentiated tumors show greater atypia and less obvious squamous maturation.

Adenocarcinoma arises from glandular epithelium and forms malignant glands containing atypical epithelial cells. Its increasing clinical importance makes recognition of both squamous and glandular cervical malignancy essential.

Clinical features

Early cervical carcinoma can be asymptomatic. When symptoms develop, bleeding is common because the tumor disrupts the cervical surface and forms fragile abnormal vessels.

Postcoital bleeding is a classic presentation because contact traumatizes the friable cervical lesion.
Intermenstrual or irregular vaginal bleeding.
Postmenopausal bleeding.
Persistent watery, blood-stained or offensive vaginal discharge.
Pelvic or back pain in more advanced disease.
Urinary or bowel symptoms when adjacent structures become involved.

On speculum examination, the cervix may appear irregular, ulcerated, fungating or friable and may bleed on contact. Advanced parametrial extension can reduce cervical mobility. Obstruction of the ureters by advanced pelvic disease may produce hydroureter and hydronephrosis.

Principles of cervical cancer staging

Cervical carcinoma is staged according to the anatomical extent of disease. The important undergraduate principle is to understand how progressively greater local extension, nodal disease and distant spread move the tumor from Stage I toward Stage IV.

Stage	Essential anatomical concept
I	Carcinoma confined to the cervix. Stage IA is microscopic invasion; Stage IB represents larger invasive disease still confined to the cervix.
II	Tumor extends beyond the uterus but has not reached the pelvic wall or lower third of the vagina. Parametrial invasion places disease in Stage IIB.
III	Involvement of the lower third of the vagina, pelvic wall, obstructive hydronephrosis/non-functioning kidney, and/or regional nodal disease.
IV	Tumor invades adjacent pelvic organs such as bladder or rectal mucosa, or spreads beyond the pelvis to distant sites.

Increasing stage reflects increasing tumor spread and therefore generally indicates a less favorable prognosis and a greater need for multimodal treatment.

AIM VISUAL 03

D. Cervical Carcinoma — Investigations, Management and Prognosis

Clinical evaluation of suspected cervical carcinoma aims first to confirm malignancy histologically and then determine the extent of disease. Management is therefore based not simply on the presence of cancer, but on tumor stage, tumor size, nodal involvement, general health and, in carefully selected early disease, fertility considerations.

Diagnostic approach

History: characterize postcoital, intermenstrual or postmenopausal bleeding, vaginal discharge, pelvic pain and symptoms of advanced disease.
Pelvic and speculum examination: identifies a visible cervical lesion and assesses local extension.
Biopsy: histological demonstration of invasive carcinoma provides definitive diagnosis.
Colposcopy-directed biopsy is useful when an abnormal epithelial area requires targeted assessment.
Imaging assists assessment of local tumor extent, lymph nodes, urinary obstruction and distant disease when clinically appropriate.

Cervical cytology and HPV testing are highly valuable in screening and precursor detection, but a suspicious invasive lesion requires tissue diagnosis.

Management principles

Management becomes more intensive as disease extends beyond the cervix. Detailed operative technique is not required at undergraduate level; the key concept is the relationship between stage and treatment modality.

Preinvasive disease: appropriately selected cervical precursor lesions are treated locally to prevent invasion.
Very early invasive disease: selected patients may be managed with conservative excisional or fertility-preserving procedures when oncologically appropriate.
Early invasive carcinoma: surgery, including hysterectomy-based treatment with appropriate nodal assessment, is an important option in suitable patients. Radiotherapy is an alternative in selected situations.
Locally advanced carcinoma: concurrent chemoradiation with brachytherapy is a major treatment principle.
Recurrent or metastatic disease: systemic treatment and symptom-directed palliative measures are considered according to disease extent and patient condition.

Prognosis

The strongest prognostic factor is the stage at diagnosis. A small tumor confined to the cervix has a much better outcome than a tumor involving pelvic structures or distant organs. Lymph-node involvement, increasing tumor size and unfavorable pathological features are also associated with poorer prognosis.

Management logic: Early localized disease can often be treated with local or surgical approaches, whereas extensive pelvic disease requires treatment capable of controlling both the primary tumor and surrounding microscopic disease.

AIM VISUAL 04

E. Endometrial Hyperplasia and Endometrial Carcinoma — Etiology, Pathogenesis and Morphology

Endometrial carcinoma arises from the lining of the uterine cavity. An important pathway begins with prolonged estrogenic stimulation without adequate progesterone opposition. This promotes repeated endometrial proliferation and can progress through atypical hyperplasia, also termed endometrial intraepithelial neoplasia (EIN), to endometrioid carcinoma. A separate aggressive pathway produces serous carcinoma, usually in an atrophic endometrium and through different molecular abnormalities.

Endometrial hyperplasia

Endometrial hyperplasia is an abnormal increase in endometrial glands relative to stroma. The clinically important distinction is whether cytological atypia is present.

Hyperplasia without atypia: increased glandular proliferation but without the marked cytological abnormalities associated with a high risk of malignant progression.
Atypical hyperplasia/EIN: crowded abnormal glands with cytological atypia and a substantially greater relationship with endometrioid carcinoma.

Etiology and risk factors for the estrogen-related pathway

Anything that produces prolonged unopposed estrogen can stimulate endometrial proliferation. Repeated proliferation increases the opportunity for neoplastic clones to arise.

Obesity, because adipose tissue contributes to peripheral estrogen formation.
Chronic anovulation, including anovulatory states such as PCOS, because progesterone exposure is reduced.
Estrogen therapy without adequate progestogenic opposition in a woman with an intact uterus.
Estrogen-producing ovarian tumors.
Nulliparity and prolonged lifetime estrogenic exposure.
Hereditary mismatch-repair abnormalities such as Lynch syndrome increase susceptibility to endometrial carcinoma through a different genetic mechanism.